Ignite Creation Date:
2025-12-24 @ 4:51 PM
Ignite Modification Date:
2026-01-26 @ 3:04 AM
Study NCT ID:
NCT00265850
Status:
COMPLETED
Last Update Posted:
2020-05-07
First Post:
2005-12-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Sponsor:
Alliance for Clinical Trials in Oncology
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Colorectal Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | recurrent colon cancer | View |
| None | stage III colon cancer | View |
| None | stage III rectal cancer | View |
| None | stage IV colon cancer | View |
| None | recurrent rectal cancer | View |
| None | stage IV rectal cancer | View |
| None | adenocarcinoma of the colon | View |
| None | adenocarcinoma of the rectum | View |